|
Christoph Rader, Ph.D., was a professor at The Scripps Research Institute and the Herbert Wertheim UF Scripps Institute for Biomedical Innovation and Technology and associate dean of the bicoastal Scripps Research graduate program. The Rader Lab’s research focused on developing and utilizing antibody display, antibody engineering, and antibody conjugation methods for improving the potency and selectivity of mAbs. Dr. Rader joined Aethon Therapeutics as Chief Technology Officer in 2023.
|
